Anxiolytic-like effect of noradrenaline microinjection into the dorsal periaqueductal gray of rats


Autoria(s): PELOSI, Gislaine G.; RESSTEL, Leonardo L. B. M.; SOARES, Vanessa R.; ZANGROSSI, Helio; GUIMARAES, Francisco S.; CORREA, Fernando M. A.
Contribuinte(s)

UNIVERSIDADE DE SÃO PAULO

Data(s)

19/10/2012

19/10/2012

2009

Resumo

The brain noradrenergic system has been implicated in the expression of defensive behaviors elicited by acute stress. The dorsal periaqueductal gray area (dPAG) is a key structure involved in the behavioral and cardiovascular responses elicited by fear and anxiety situations. Although there are noradrenergic terminals in the dPAG, few studies have investigated the role of noradrenaline (NA) in the dPAG on anxiety modulation. The aim of this study was to evaluate the effect of NA microinjection into the dPAG of rats subjected to two animal models of anxiety, the elevated plus-maze and the Vogel conflict test. Male Wistar rats implanted with a guide cannula aimed at the dPAG received microinjections of NA (3, 15, or 45 nmol/0.05 mu l) or artificial cerebral spinal fluid into the dPAG immediately before being exposed to the elevated plus-maze or the Vogel conflict test. NA increased the exploration of the open arms and the number of enclosed arm entries in the elevated plus-maze. The increase in open arm exploration remained significant after being subjected to an analysis of covariance using the latter variable as covariate. Moreover, the NA microinjection into the dPAG did not increase general exploratory activity of animals subjected to the open-field test, indicating that the increase in open arm exploration cannot be attributed to a nonspecific increase in exploratory activity. In the Vogel test, the NA microinjection into the dPAG increased the number of punished licks without changing the number of nonpunished licks or interfering with the tail-flick test. The results, therefore, indicate that the NA microinjection into the dPAG produces anxiolytic-like effects, suggesting its possible involvement in the anxiety modulation. Behavioural Pharmacology 20:252-259 (C) 2009 Wolters Kluwer Health vertical bar Lippincott Williams & Wilkins.

Fapesp

Identificador

BEHAVIOURAL PHARMACOLOGY, v.20, n.3, p.252-259, 2009

0955-8810

http://producao.usp.br/handle/BDPI/24183

10.1097/FBP.0b013e32832c7098

http://dx.doi.org/10.1097/FBP.0b013e32832c7098

Idioma(s)

eng

Publicador

LIPPINCOTT WILLIAMS & WILKINS

Relação

Behavioural Pharmacology

Direitos

closedAccess

Copyright LIPPINCOTT WILLIAMS & WILKINS

Palavras-Chave #anxiety #dorsal periaqueductal gray #elevated plus-maze #noradrenaline #rat #Vogel conflict test #ELEVATED PLUS-MAZE #VOGEL CONFLICT TEST #ANTI-ANXIETY AGENTS #DEFENSIVE BEHAVIOR #LOCUS-COERULEUS #ANIMAL-MODELS #NEUROENDOCRINE RESPONSES #FREEZING BEHAVIOR #STRIA TERMINALIS #DISTINCT REGIONS #Behavioral Sciences #Neurosciences #Pharmacology & Pharmacy
Tipo

article

original article

publishedVersion